Skip to main content
Equibles

PRN · Profound Medical Corp. · Webcasts, Transcripts & Audio

Use PRN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PRN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
10.1400 CAD +0.5000 (+5.19%) At close · Nov 6 Intraday price with Plus
Rebalance outlook locked

Profound Medical Corp. Webcasts

Earnings calls, investor updates, investor days and conferences for Profound Medical Corp. (PRN), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Embed Profound Medical Corp. earnings calls on your site

Pick a widget, match your page, then paste the code where it should appear.

Widget
Theme
Accent color Pro

Match your site's colors with Pro. The Equibles credit stays on every plan.

Embed code 

                    
The widget credits Equibles and keeps the link below it on every plan.

                

            


            

                Preview
                
            

        

        
    

    




    


    
    

        

            
            
            
            
        

            

                
                    
                    
                    
                    
                    
                    
                    
            

        
        
    


    
    

            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY26 · Q3

                    
2026-11-05

                


                
                

                    
Profound Medical Corp. (PRN) Q3 2026 Earnings Call Transcript

                    

                            
                                Confident tone
                            
                                Financial growth and guidance
                                Clinical differentiation and evidence
                                Cook Medical partnership
                    

                


                
                

                        

                                

                                    
Revenue

                                    
$9.83M

▲ 85.9% YoY                                

                                

                                    
Diluted EPS

                                    
$-0.21

                                

                                

                                    
Gross margin

                                    
78.1%

                                

                                

                                    Rev · 8q
                                    Trailing quarterly revenue
                                

                        

                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY26 · Q2

                    
2026-08-06

                


                
                

                    
Profound Medical Corp. (PRN) Q2 2026 Earnings Call Transcript

                    

                            
                                Confident tone
                            
                                Tulsa clinical evidence and CAPTAIN trial
                                Commercial momentum and sales pipeline
                                Reimbursement and payer coverage expansion
                    

                


                
                

                        

                                

                                    
Revenue

                                    
$2.48M

▲ 12.3% YoY                                

                                

                                    
Diluted EPS

                                    
$-0.26

                                

                                

                                    
Gross margin

                                    
78.4%

                                

                                

                                    Rev · 8q
                                    Trailing quarterly revenue
                                

                        

                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY26 · Q1

                    
2026-05-07

                


                
                

                    
Profound Medical Corp. (PRN) Q1 2026 Earnings Call

                    

                    

                


                
                

                        

                                

                                    
Revenue

                                    
$5.34M

▲ 103.6% YoY                                

                                

                                    
Diluted EPS

                                    
$0.19

▼ 47.2% YoY                                

                                

                                    
Gross margin

                                    
71.8%

                                

                                

                                    Rev · 7q
                                    Trailing quarterly revenue
                                

                        

                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY25 · Q4

                    
2026-03-05

                


                
                

                    
Profound Medical Corp. (PRN) Q4 2025 Earnings Call Transcript

                    

                            
                                Confident tone
                            
                                CAPTAIN trial and clinical evidence
                                Revenue growth and financials
                                Installed base growth and utilization targets
                    

                


                
                

                        

                                

                                    
Revenue

                                    
$5.98M*

▲ 43.1% YoY                                

                                

                                    
Gross margin

                                    
66.8%

                                

                                

                                    Rev · 6q
                                    Trailing quarterly revenue
                                

                        

                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-K                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY25 · Q3

                    
2025-10-07

                


                
                

                    
Profound Medical Corp. (PRN) Q3 2025 Earnings Call Transcript

                    

                            
                                Confident tone
                            
                                TULSA-AI Volume Reduction software launch
                                BPH market expansion
                                Revenue growth and profitability trajectory
                    

                


                
                

                        

                                

                                    
Revenue

                                    
$5.29M

▲ 86.8% YoY                                

                                

                                    
Diluted EPS

                                    
$-0.26

▼ 168.4% YoY                                

                                

                                    
Gross margin

                                    
74.3%

                                

                                

                                    Rev · 6q
                                    Trailing quarterly revenue
                                

                        

                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY25 · Q2

                    
2025-08-14

                


                
                

                    
Profound Medical Corp. (PRN) Q2 2025 Earnings Call Transcript

                    

                            
                                Positive tone
                            
                                Software upgrade / procedure time
                                CAPTAIN trial milestones
                                Sales pipeline and funnel
                    

                


                
                

                        

                                

                                    
Revenue

                                    
$2.21M

▼ 1% YoY                                

                                

                                    
Diluted EPS

                                    
$-0.52

▼ 285.7% YoY                                

                                

                                    
Gross margin

                                    
73.2%

                                

                                

                                    Rev · 5q
                                    Trailing quarterly revenue
                                

                        

                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY25 · Q1

                    
2025-05-08

                


                
                

                    
Profound Medical Corp. (PRN) Q1 2025 Earnings Call Transcript

                    

                            
                                Confident tone
                            
                                TULSA-PRO clinical differentiation and CAPTAIN trial
                                TULSA+ bundled offering with MRI partners
                                Pipeline of cancer centers and adoption cycle
                    

                


                
                

                        

                                

                                    
Revenue

                                    
$2.62M

▲ 82.1% YoY                                

                                

                                    
Diluted EPS

                                    
$0.36

▲ 33.3% YoY                                

                                

                                    
Gross margin

                                    
70.7%

                                

                                

                                    Rev · 4q
                                    Trailing quarterly revenue
                                

                        

                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Capital Markets Day
                    

                        
Investor event

                    
2025-04-28

                


                
                

                    
Profound Medical Corp. (PRN) April 28, 2025 Capital Markets Day Transcript

                    

                    

                


                
                

                        No reported result — non-financial event
                


                
                

                    Audio
                    Transcript
                    Slides
                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY24 · Q4

                    
2025-03-07

                


                
                

                    
Profound Medical Corp. (PRN) Q4 2024 Earnings Call Transcript

                    

                            
                                Confident tone
                            
                                TULSA-PRO technology and precision
                                Commercial organization and capital sales model
                                Reimbursement and Medicare payments
                    

                


                
                

                        

                                

                                    
Revenue

                                    
$4.18M*

                                

                                

                                    
Gross margin

                                    
70.9%

                                

                                

                                    Rev · 3q
                                    Trailing quarterly revenue
                                

                        

                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-K                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY24 · Q3

                    
2024-09-30

                        
Date not confirmed

                


                
                

                    
Profound Medical Corp. (PRN) Q3 2024 Earnings Call Transcript

                    

                            
                                Confident tone
                            
                                TULSA procedure and clinical flexibility
                                Reimbursement and CPT Category 1 codes
                                TULSA Plus and Siemens partnership
                    

                


                
                

                        

                                

                                    
Revenue

                                    
$2.83M

                                

                                

                                    
Diluted EPS

                                    
$0.38

                                

                                

                                    
Gross margin

                                    
63.1%

                                

                                

                                    Rev · 3q
                                    Trailing quarterly revenue
                                

                        

                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY24 · Q2

                    
2024-06-30

                        
Date not confirmed

                


                
                

                    
Profound Medical Corp. (PRN) Q2 2024 Earnings Call Transcript

                    

                            
                                Positive tone
                            
                                Real-world TULSA utilization
                                Reimbursement and CPT codes
                                Procedure throughput and economics
                    

                


                
                

                        

                                

                                    
Revenue

                                    
$2.23M

                                

                                

                                    
Diluted EPS

                                    
$0.28

                                

                                

                                    
Gross margin

                                    
63.6%

                                

                                

                                    Rev · 2q
                                    Trailing quarterly revenue
                                

                        

                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY24 · Q1

                    
2024-03-31

                        
Date not confirmed

                


                
                

                    
Profound Medical Corp. (PRN) Q1 2024 Earnings Call Transcript

                    

                            
                                Confident tone
                            
                                Recurring revenue and utilization growth
                                Indication breadth and patient spectrum
                                Reimbursement and CMS pricing
                    

                


                
                

                        

                                

                                    
Revenue

                                    
$1.44M

                                

                                

                                    
Diluted EPS

                                    
$0.27

                                

                                

                                    
Gross margin

                                    
60.2%

                                

                        

                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY23 · Q4

                    
2023-12-31

                        
Date not confirmed

                


                
                

                    
Profound Medical Corp. (PRN) Q4 2023 Earnings Call Transcript

                    

                    

                


                
                

                        Results not yet reported
                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-K                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY23 · Q3

                    
2023-09-30

                        
Date not confirmed

                


                
                

                    
Profound Medical Corp. (PRN) Q3 2023 Earnings Call Transcript

                    

                    

                


                
                

                        Results not yet reported
                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY23 · Q2

                    
2023-06-30

                        
Date not confirmed

                


                
                

                    
Profound Medical Corp. (PRN) Q2 2023 Earnings Call Transcript

                    

                    

                


                
                

                        Results not yet reported
                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY23 · Q1

                    
2023-03-31

                        
Date not confirmed

                


                
                

                    
Profound Medical Corp. (PRN) Q1 2023 Earnings Call Transcript

                    

                    

                


                
                

                        Results not yet reported
                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY22 · Q4

                    
2022-12-31

                        
Date not confirmed

                


                
                

                    
Profound Medical Corp. (PRN) Q4 2022 Earnings Call Transcript

                    

                    

                


                
                

                        Results not yet reported
                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-K                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY22 · Q3

                    
2022-09-30

                        
Date not confirmed

                


                
                

                    
Profound Medical Corp. (PRN) Q3 2022 Earnings Call Transcript

                    

                    

                


                
                

                        Results not yet reported
                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY22 · Q2

                    
2022-06-30

                        
Date not confirmed

                


                
                

                    
Profound Medical Corp. (PRN) Q2 2022 Earnings Call Transcript

                    

                    

                


                
                

                        Results not yet reported
                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY22 · Q1

                    
2022-03-31

                        
Date not confirmed

                


                
                

                    
Profound Medical Corp. (PRN) Q1 2022 Earnings Call Transcript

                    

                    

                


                
                

                        Results not yet reported
                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY21 · Q4

                    
2021-12-31

                        
Date not confirmed

                


                
                

                    
Profound Medical Corp. (PRN) Q4 2021 Earnings Call Transcript

                    

                    

                


                
                

                        Results not yet reported
                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-K                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY21 · Q3

                    
2021-09-30

                        
Date not confirmed

                


                
                

                    
Profound Medical Corp. (PRN) Q3 2021 Earnings Call Transcript

                    

                    

                


                
                

                        Results not yet reported
                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY21 · Q2

                    
2021-06-30

                        
Date not confirmed

                


                
                

                    
Profound Medical Corp. (PRN) Q2 2021 Earnings Call Transcript

                    

                    

                


                
                

                        Results not yet reported
                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY21 · Q1

                    
2021-03-31

                        
Date not confirmed

                


                
                

                    
Profound Medical Corp. (PRN) Q1 2021 Earnings Call Transcript

                    

                    

                


                
                

                        Results not yet reported
                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY20 · Q4

                    
2020-12-31

                        
Date not confirmed

                


                
                

                    
Profound Medical Corp. (PRN) Q4 2020 Earnings Call Transcript

                    

                    

                


                
                

                        Results not yet reported
                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-K                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY20 · Q3

                    
2020-09-30

                        
Date not confirmed

                


                
                

                    
Profound Medical Corp. (PRN) Q3 2020 Earnings Call Transcript

                    

                    

                


                
                

                        Results not yet reported
                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY20 · Q2

                    
2020-06-30

                        
Date not confirmed

                


                
                

                    
Profound Medical Corp. (PRN) Q2 2020 Earnings Call Transcript

                    

                    

                


                
                

                        Results not yet reported
                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY20 · Q1

                    
2020-03-31

                        
Date not confirmed

                


                
                

                    
Profound Medical Corp. (PRN) Q1 2020 Earnings Call Transcript

                    

                    

                


                
                

                        Results not yet reported
                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
    

    

        
Showing 1–28 of 28 webcasts